Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Vortioxetine is approved for the treatment of adults with major depressive disorder. This open-label extension (OLE) study evaluated the safety and tolerability of vortioxetine in the long-term treatment of major depressive disorder patients, as well as evaluated its effectiveness using measures of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsen, Paula L., Harper, Linda, Chrones, Lambros, Chan, Serena, Mahableshwarkar, Atul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525811/
https://www.ncbi.nlm.nih.gov/pubmed/26020712
http://dx.doi.org/10.1097/YIC.0000000000000081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525811/
https://www.ncbi.nlm.nih.gov/pubmed/26020712
http://dx.doi.org/10.1097/YIC.0000000000000081

Ejemplares similares